Annual Debt To Equity
0.94
-0.32-25.40%
December 31, 2023
Summary
- As of February 11, 2025, RPRX annual debt to equity ratio is 0.94, with the most recent change of -0.32 (-25.40%) on December 31, 2023.
- During the last 3 years, RPRX annual debt to equity has fallen by -0.27 (-22.31%).
- RPRX annual debt to equity is now -35.17% below its all-time high of 1.45, reached on December 31, 2018.
Performance
RPRX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
1.11
-0.06-5.13%
September 30, 2024
Summary
- As of February 11, 2025, RPRX quarterly debt to equity ratio is 1.11, with the most recent change of -0.06 (-5.13%) on September 30, 2024.
- Over the past year, RPRX quarterly debt to equity has increased by +0.17 (+18.09%).
- RPRX quarterly debt to equity is now -21.83% below its all-time high of 1.42, reached on June 30, 2020.
Performance
RPRX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RPRX Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.4% | +18.1% |
| 3 y3 years | -22.3% | +18.1% |
| 5 y5 years | -35.2% | - |
RPRX Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.4% | at low | -11.9% | +18.1% |
| 5 y | 5-year | -25.4% | at low | -21.8% | +18.1% |
| alltime | all time | -35.2% | at low | -21.8% | +18.1% |
Royalty Pharma Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 1.11(-5.1%) |
| Jun 2024 | - | 1.17(+24.5%) |
| Mar 2024 | - | 0.94(0.0%) |
| Dec 2023 | 0.94(-25.4%) | 0.94(-6.0%) |
| Sep 2023 | - | 1.00(-11.5%) |
| Jun 2023 | - | 1.13(-5.8%) |
| Mar 2023 | - | 1.20(-4.8%) |
| Dec 2022 | 1.26 | 1.26(+8.6%) |
| Sep 2022 | - | 1.16(-1.7%) |
| Jun 2022 | - | 1.18(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 1.23(0.0%) |
| Dec 2021 | 1.23(+1.7%) | 1.23(+0.8%) |
| Sep 2021 | - | 1.22(+19.6%) |
| Jun 2021 | - | 1.02(-14.3%) |
| Mar 2021 | - | 1.19(-1.7%) |
| Dec 2020 | 1.21(+18.6%) | 1.21(-7.6%) |
| Sep 2020 | - | 1.31(-7.7%) |
| Jun 2020 | - | 1.42(+23.5%) |
| Mar 2020 | - | 1.15(+12.7%) |
| Dec 2019 | 1.02(-29.7%) | 1.02 |
| Dec 2018 | 1.45 | - |
FAQ
- What is Royalty Pharma annual debt to equity ratio?
- What is the all time high annual debt to equity for Royalty Pharma?
- What is Royalty Pharma annual debt to equity year-on-year change?
- What is Royalty Pharma quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Royalty Pharma?
- What is Royalty Pharma quarterly debt to equity year-on-year change?
What is Royalty Pharma annual debt to equity ratio?
The current annual debt to equity of RPRX is 0.94
What is the all time high annual debt to equity for Royalty Pharma?
Royalty Pharma all-time high annual debt to equity ratio is 1.45
What is Royalty Pharma annual debt to equity year-on-year change?
Over the past year, RPRX annual debt to equity ratio has changed by -0.32 (-25.40%)
What is Royalty Pharma quarterly debt to equity ratio?
The current quarterly debt to equity of RPRX is 1.11
What is the all time high quarterly debt to equity for Royalty Pharma?
Royalty Pharma all-time high quarterly debt to equity ratio is 1.42
What is Royalty Pharma quarterly debt to equity year-on-year change?
Over the past year, RPRX quarterly debt to equity ratio has changed by +0.17 (+18.09%)